Valuation: Boston Scientific Corporation

Market Cap 63.87B 56.17B 52.18B 47.99B 90.01B 6,185B 91.62B 624B 243B 3,017B 240B 235B 10,466B P/E 2026 *
15.6x
P/E 2027 * 15.1x
Enterprise Value 70.43B 61.94B 57.54B 52.92B 99.25B 6,820B 101B 688B 268B 3,327B 264B 259B 11,541B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 2.89x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day-1.35%
1 week+1.25%
Current month+2.11%
1 month-1.69%
3 months-32.82%
6 months-52.26%
Current year-54.29%
1 week 42.5
Extreme 42.5
45.25
1 month 42.2
Extreme 42.2
46.37
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
28/05/26 Don

Chief Executive Officer

-386,755 0.0261%
20/05/26 Buy

Director

1,770 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%+1.25%-57.75%-18.02% 63.87B
+8.71%+6.92%+33.84%+1.80% 196B
+7.46%-4.13%+1.36%-24.77% 126B
-2.54%-14.64%-35.03%-1.38% 120B
-0.65%-3.95%+9.86%-9.45% 48.58B
-1.56%-2.07%-25.50%-33.72% 43.93B
+4.71%+3.73%+20.27%+9.50% 37.69B
+3.13%+2.00%+33.03%+32.45% 36.41B
+3.14%+5.19%+92.94%+3.34% 28.88B
+0.94%-1.91%-18.96%-24.98% 27.93B
Average +2.20%-3.33%+5.41%-6.52% 72.92B
Weighted average by Cap. +3.51%-4.91%+3.25%-6.97%

Financials

2026 *2027 *
Net sales 21.57B 18.97B 17.63B 16.21B 30.4B 2,089B 30.95B 211B 82.21B 1,019B 80.99B 79.24B 3,535B 23.32B 20.51B 19.06B 17.53B 32.87B 2,259B 33.46B 228B 88.88B 1,102B 87.56B 85.67B 3,822B
Net income 3.94B 3.47B 3.22B 2.96B 5.55B 382B 5.65B 38.5B 15.02B 186B 14.79B 14.47B 646B 4.13B 3.64B 3.38B 3.11B 5.82B 400B 5.93B 40.38B 15.75B 195B 15.52B 15.18B 677B
Net Debt 6.56B 5.77B 5.36B 4.93B 9.24B 635B 9.41B 64.08B 24.99B 310B 24.62B 24.09B 1,075B 3.43B 3.01B 2.8B 2.57B 4.83B 332B 4.91B 33.47B 13.05B 162B 12.86B 12.58B 561B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
23/07/26 $43.58 +1.42% 16,438,771
22/07/26 $42.97 -0.51% 11,201,174
21/07/26 $43.19 -1.33% 25,009,837
20/07/26 $43.77 -0.59% 13,129,888
17/07/26 $44.03 -1.32% 15,522,226
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
43.58USD
Average target price
72.43USD
Spread / Average Target
+66.20%

Quarterly revenue - Rate of surprise